Description: A look back over 20 years to see how product topics of the day have changed and remained the same.

Description: Under long-duration targeted improvements (LDTI), there are a few insurance liability balances that now are required to be fair valued, market risk benefit (MRB). The session will start from all the applicable balances that are required to be fair valued under LDTI ((i.e., MRB, financial accounting statement (FAS) 133, value of business acquired (VOBA) upon business combination)). The session will use a case study to discuss some of the nuances and general considerations for an MRB, FAS 133 and VOBA balances for a business combination for an fixed indexed annuity (FIA) contract. The case study will discuss some MRB fair value considerations and followed by FAS 133 fair value techniques. It will go over VOBA fair value estimation by using actuarial appraisal method with a few twists (e.g., using market yield in generating distributable earnings is better than using book yield and adjusted to bring it to fair value later on).

Description: By attending the session, you will learn: - Different perspectives around what FP&A is used for (e.g., strategic planning, performance measurement, management compensation, liquidity management, etc.) and why - Challenges leaders have faced and how they are being addressing - How recent regulatory, accounting, and technological change has impacted the FP&A function - Objectives for various organizations around both new analytics for business management, efficient production of forecast results, and potential for faster 'top down' forecasting

Description: Value of new business (VNB) is being used by many companies for various purposes including: internal and external financial reporting, incentive compensation, pricing, capital management, and comparing products, distribution channels or regions on a consistent basis. Presenters will discuss how and why value of new business is used within their companies including: the various methodologies considered, some of the benefits and challenges related to implementing VNB, integrating VNB within their business as usual processes, and managing to VNB.

Description: Join us for an exciting session as Actuarial Innovation & Technology Strategic Research from the SOA's Research Institute unveils two recently published research reports: ""Unveiling the Life Insurers' Actuarial Transformation Journey and the Impact of Analytics"" and ""Exploring Revolutionary Advances in Underwriting: An Initial Assessment of Epigenetics, Medical Tests, and Wearables"". In the first report, we delve into the evolving landscape of life insurers' Actuarial Transformation efforts, shedding light on their future prospects and emphasizing emerging Advanced Analytics techniques. The second report serves as the inaugural installment of a series dedicated to identifying promising innovations for underwriters and actuaries, and it promises to alert the SOA to the latest developments. During this session, our presenters will provide an insightful overview of the key findings and key takeaways from both research reports. By the end of the session, attendees will gain a deeper understanding and appreciation for the invaluable research conducted in these areas.

Description: Hear diverse perspectives from both a reinsurer and carrier on how to best structure financial reinsurance transactions. Join us as we consider various ceding company objectives as well as impacts from the dynamic economic and regulatory environment. By attending this session, you will be able to: - Better understand common reinsurance transactions - Evaluate whether reinsurance transactions can help you meet your company's objectives and challenges - Gain an appreciation for the ever-changing economic and regulatory environment

Description: In this webinar, the presenters will give a behind the scenes look at how the NAIC ESG was parameterized. They will also share the results of its most recent calibration.

Description: Discuss issues related to illustrations, including illustration testing, ASOP 24, the illustration model regulation and AG 49 at the practice level. Come prepared with questions and comments on the world of illustrations and illustration testing. Explore ideas for what's working and not working in the illustration world and formulate plans to tackle pressing illustrations issues. At the end of this workshop, you will be able to Identify issues related to illustrations and illustration testing for life products, discuss possible ways to resolve issues issue identified, and explore the future state of illustrations and illustration testing for various products.

Description: Experts from both the direct and reinsurance side of the table will provide an overview of final expense products and their key features, as well as share experiences that have informed best practices when designing, selling, managing, monitoring and reinsuring these products. Trends in distribution, underwriting tools and other competitive factors will be considered through the lens of managing risk while remaining competitive in the market.

Description: Mortality improvement for the U.S. general population has stagnated in recent years and then further deteriorated with the COVID-19 pandemic. However, mortality improvement by socioeconomic factors such as education and income has varied widely during this time period. Explore with us cause-of-death mortality rate trends as well as overall mortality improvement trends by different socioeconomic factors. Join a discussion on approaches that companies can take to proxy the insured population by applying socioeconomic factors to the general population with the goal of better understanding future mortality trends for the insured population.